Solasta Bio

Private

Glasgow, ScotlandHealthcare & Life Scienceswww.solastabio.com

Last Round

Series A

Sep 11, 2024

Total Funding Raised

$20.77M

Company Overview

Solasta Bio is an agricultural biotechnology company that develops biological pesticides and neuropeptide-based insect control products for effective and sustainable crop protection.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Sustainable Materials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

bioinsecticidespeptide insecticidescrop protectionbiopesticidesinsect control agentsICAsag biologicalspollinator safeagtechtarget-specific insecticidessustainable crop protectionpeptide discoverypest managementbee safe pesticidesagri-bioinsect resistance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Solasta Bio Comps

Public and private peers based on sector, stage, and business model.

Solasta Bio comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Solasta Bio Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Sep 11, 2024
Seed	Apr 11, 2023
Seed	Aug 16, 2021

View all Funding Rounds

Key People

Founding team and executive leadership

Shireen Davies

Chief Executive Officer

Executive Team

Solasta Bio Investors

Notable investors and investment history

Solasta Bio investors
Investor	Rounds
University of Glasgow	Series A
FMC Ventures	Series A
Cavallo Ventures	Seed, Series A
Yield Lab Europe	Seed
Cambridge Agritech	Seed
UK Innovation & Science Seed Fund	Seed, Series A
Rubio Impact Ventures	Seed, Series A

View all Investors

Market signals

Structured signals derived from secondary market and firmographic data.

Oct 22, 2025
CSO Paula Pinto spoke at the Annual Biocontrol Industry Meeting 2025.

View all signals

Solasta Bio Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Solasta Bio Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Solasta Bio's valuation, stock price, and market status.

Firmographic Details

HeadquartersGlasgow, Scotland

Employee Range38

Year Founded2020

Last FundingSep 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.